North America Artificial Cornea and Corneal Implant Market Analysis and Opportunities by 2028
Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028North America Artificial Cornea and Corneal Implant Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Human Cornea and Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty, and Others), Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, and Others), and End User (Hospitals, Specialty Clinics and ASCs, and Others)
- Report Date : Nov 2021
- Report Code : TIPRE00025843
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 109
The North America artificial cornea and corneal implant market is expected to reach US$ 272.13 million by 2028 from US$ 162.29 million in 2021; it is estimated to grow at a CAGR of 7.7% from 2021–2028.
The growth of the Artificial Cornea and Corneal Implant market is attributed to key factors such as the growing prevalence of eye diseases that can cause corneal blindness and rising elderly population. However, the expensive ophthalmology surgeries and devices hamper the market growth.
Corneal diseases are the second-leading cause of blindness worldwide, after cataract. According to the World Health Organization (WHO), at least 2.2 billion people in the world will have near or far vision impairment by February 2020. These 1 billion people include people with moderate or severe distance vision impairment or blindness due to refractive errors (88.4 million), cataracts (94 million), glaucoma (7.7 million), corneal opacity (4.2 million), diabetes Retinopathy (3.9 million), trachoma (2 million), and near vision weakness due to unresolved presbyopia (826 million). Population growth and aging would further propel the risk of visual impairment among a larger number of people. According to the National Eye Institute, the number of persons suffering from cataract would rise from 24.4 million in 2010 to ~50 million by 2050. As populations age and average life expectancy continues to increase worldwide, the number of people with cataracts will continue to grow. Furthermore, people over 60 years of age; steroid users; and family members of those who have been diagnosed with glaucoma; people suffering from diabetes, high myopia, and hypertension, and eye injuries are at a greater risk of glaucoma. Thus, the rising prevalence of eye diseases that causes corneal blindness worldwide highly demands artificial cornea and corneal implant. Also, the rise in geriatric population is fuelling the artificial cornea and corneal implant market growth.
The COVID-19 outbreak in North America had a significant impact on the US. Various healthcare research centers across the country were solely focused on COVID-19 treatments. On the other hand, to prevent the spread of the novel coronavirus, the number of patient visits to clinics decreased significantly in the first and second quarters of 2020. As a result, the number of elective eye procedures performed per week in hospitals and clinics has decreased over time. According to an article in Ophthalmology Times, the number of elective procedures has decreased from 200 to only 10 each week in U.S. In addition, the number of patient visits to examination facilities has decreased by 15% in countries, such as the US. Also, it is predicated that the volume of ophthalmic practice has decreased by 81%, owing to a decline in patients seeking care for glaucoma (88%) and cataract surgery (81%) (97%). During this time, government assistance such as Paycheck Protection Program loans aided many practices, allowing the ophthalmic business to successfully resume operations. Ophthalmologists will benefit from such a scenario since it will allow them to resume their work safely.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET SEGMENTATION
By Type
- Human Cornea
- Artificial Cornea
By Transplant Type
- Penetrating Keratoplasty
- Endothelial Keratoplasty
- Others
By Disease Indication
- Fuchs’ Dystrophy
- Keratoconus
- Fungal Keratitis
- Others
By End User
- Hospitals
- Specialty Clinics and ASCs
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- AJL OPHTHALMIC S.A
- ADVANCING SIGHT NETWORK
- CORNEA BIOSCIENCES, INC
- KERAMED, INC
- EyeYon Medical
- Florida Lions Eye Bank
- CorneaGen
North America Artificial Cornea and Corneal Implant Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 162.29 Million |
| Market Size by 2028 | US$ 272.13 Million |
| Global CAGR (2021 - 2028) | 7.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
- AJL OPHTHALMIC S.A
- ADVANCING SIGHT NETWORK
- CORNEA BIOSCIENCES, INC
- KERAMED, INC
- EyeYon Medical
- Florida Lions Eye Bank
- CorneaGen
Get Free Sample For